BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27974047)

  • 21. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors.
    Lee JH; Shin SJ; Choe EA; Kim J; Hyung WJ; Kim HS; Jung M; Beom SH; Kim TI; Ahn JB; Chung HC; Shin SJ
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.
    Belinsky MG; Rink L; Cai KQ; Capuzzi SJ; Hoang Y; Chien J; Godwin AK; von Mehren M
    BMC Cancer; 2015 Nov; 15():887. PubMed ID: 26555092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation status of known methylation-sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c-kit and PDGFRA gene mutations and their malignancy.
    Saito K; Sakurai S; Sano T; Sakamoto K; Asao T; Hosoya Y; Nakajima T; Kuwano H
    Cancer Sci; 2008 Feb; 99(2):253-9. PubMed ID: 18271923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST).
    Daniels M; Lurkin I; Pauli R; Erbstösser E; Hildebrandt U; Hellwig K; Zschille U; Lüders P; Krüger G; Knolle J; Stengel B; Prall F; Hertel K; Lobeck H; Popp B; Theissig F; Wünsch P; Zwarthoff E; Agaimy A; Schneider-Stock R
    Cancer Lett; 2011 Dec; 312(1):43-54. PubMed ID: 21906875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST.
    Astolfi A; Indio V; Nannini M; Saponara M; Schipani A; De Leo A; Altimari A; Vincenzi B; Comandini D; Grignani G; Secchiero P; Urbini M; Pantaleo MA
    Front Oncol; 2020; 10():504. PubMed ID: 32391261
    [No Abstract]   [Full Text] [Related]  

  • 30. Recurrent epimutation of SDHC in gastrointestinal stromal tumors.
    Killian JK; Miettinen M; Walker RL; Wang Y; Zhu YJ; Waterfall JJ; Noyes N; Retnakumar P; Yang Z; Smith WI; Killian MS; Lau CC; Pineda M; Walling J; Stevenson H; Smith C; Wang Z; Lasota J; Kim SY; Boikos SA; Helman LJ; Meltzer PS
    Sci Transl Med; 2014 Dec; 6(268):268ra177. PubMed ID: 25540324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS).
    Saponara M; Urbini M; Astolfi A; Indio V; Ercolani G; Del Gaudio M; Santini D; Pirini MG; Fiorentino M; Nannini M; Lolli C; Mandrioli A; Gatto L; Brandi G; Biasco G; Pinna AD; Pantaleo MA
    Oncotarget; 2015 Dec; 6(39):42243-57. PubMed ID: 26544626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.
    Kang HJ; Koh KH; Yang E; You KT; Kim HJ; Paik YK; Kim H
    Proteomics; 2006 Feb; 6(4):1151-7. PubMed ID: 16402362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
    de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E
    Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
    Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
    Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
    Buleje J; Acosta Ó; Guevara-Fujita M; Enriquez Y; Taxa L; Machicado E; Lizaraso-Caparó F; Fujita R
    Rev Esp Enferm Dig; 2015 Feb; 107(2):72-8. PubMed ID: 25659388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Gao J; Li J; Li Y; Li Z; Gong J; Wu J; Liu N; Dong B; Qi C; Li J; Shen L
    Oncotarget; 2016 May; 7(21):30241-9. PubMed ID: 26848617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number.
    Astolfi A; Nannini M; Pantaleo MA; Di Battista M; Heinrich MC; Santini D; Catena F; Corless CL; Maleddu A; Saponara M; Lolli C; Di Scioscio V; Formica S; Biasco G
    Lab Invest; 2010 Sep; 90(9):1285-94. PubMed ID: 20548289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.